sample

The ESMO Congress is a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. https://www.esmo.org/

 

Several projects in which we collaborated were presented in October in Madrid:

 

POSTERS

 

Acupuncture in patients (pts) with digestive cancer and oxaliplatin-induced peripheral neuropathy (OIPN): Results of the ACUPOX phase II GERCOR G-114 study

Authors

Emmanuelle Kempf (Creteil, France) Bouras Amina (Créteil, France) Patricia Walleck (Paris, France) Carolina Saldana (Creteil, France) Charlotte Fenioux (Creteil, France) Helene Boussion (Paris, France) Eida Bui (Paris, France) Isabelle Cojean-Zelek (Créteil, France) Anne Rohan (Paris, France) Olivier Caliez (Creteil, France) Jean-Baptiste Bachet (Paris, France) Tam Nhan (Bobigny, France) Eliane Tang (Nanterre, France) Camille Herve (Grenoble, France) Yves Delplanque (Grenoble, France) Cyril Boisson (Besancon, France) Dewi Vernerey (Besancon, France) Marie Line Garcia Larnicol (Paris, France) Christophe Tournigand (Creteil, France, CEDEX) Philippe Jeannin (Paris, France)

 

Optimizing 1st-line NALIRIFOX and Exploring the Role of Microbiota in 2nd-line Pancreatic Cancer Treatment: The PRODIGE 105 GERCOR PANORAMIX study   

Authors

Cindy Neuzillet (Boulogne-Billancourt, France) Matthieu Delaye (Paris, France) Marc Hilmi (New York, United States of America) Paul Gougis (Paris, France) Brice Chanez (Marseille, France) Gael Roth (La Tronche, France) Victoire De Lastours (Clichy, France) Victoire Ruffino (Paris, France) Marie Line Garcia Larnicol (Paris, France) Jean-Baptiste Bachet (Paris, France) Dewi Vernerey (Besancon, France)

 

Trifluridine/tipiracil and bevacizumab in refractory metastatic colorectal cancer patients : An AGEO prospective multicenter real-world study

Authors

Flavie Soumagne (Paris, France) Anais Jenvrin (Paris, France) Isabelle Trouilloud (Paris, France) Antoine Falcoz (Besancon, France) Alice Boileve (Villejuif, France) Jerome Desrame (Lyon, France, CEDEX 8) Jean-Baptiste Bachet (Paris, France) Laurent Mineur (Avignon, France, CEDEX 2) Anthony Turpin (Lille, France) Debora Basile (Crotone, Italy) Olivier Dubreuil (Paris, France) Marie Muller (Nancy, France) Lysiane Marthey (Le Kremlin-Bicêtre, France) Romain Desgrippes (Saint Malo, France) Gael Goujon (Paris, France) Matthieu Delaye (Paris, France) Anna Pellat (Paris, France) Ronaldo Elkaddoum (Paris, France) David Tougeron (Poitiers, France, CEDEX) Julien Taieb (Paris, France)

 

Beyond clinical risk: Real-world insights from genomic profiling in early breast cancer – the FREDO-ODX study

Authors

Elsa Curtit (Besancon, France) Marc-Antoine Benderra (Paris, France) Julie Henriques (Besancon, France) Sandra Assoun (Paris, France) Claire Giraud Genouville (Dechy, France) Fatima MENIAI (Beauvais, France) Cristian Villanueva (Montpellier, France) Sylvain Ladoire (Dijon, France, Cedex) Aurelie Fadin (Reims, France) Alexandre M. Henni (Arras, France) Jean-Baptiste AISENFARB (Dunkerque, France) Caroline Bailleux (Nice, France) Fernando Bazan (Clermont-Ferrand, France) Alice Pham Becker (Lens, France, Pas de Calais) Emmanuelle Jacquet (La Tronche, France) Anne-Catherine Degrendel (Dunkerque, France) Dorothee Chocteau (Nantes, France) Dewi Vernerey (Besancon, France) Joseph Gligorov (Paris, France) Eric-Charles Antoine (Neuilly-sur-Seine, France)

 

 

First-line (L1) durvalumab with chemotherapy (D+CT) in advanced biliary tract cancer (aBTC): A retrospective DIVA sub-study of the French ACABi PRONOBIL GERCOR cohort

Authors

Matthieu Delaye (Paris, France) Julie Henriques (Besancon, France) Christophe Tournigand (Creteil, France, CEDEX) Alice Boileve (Villejuif, France) Thomas Walter (Lyon, France) Sylvain Manfredi (Dijon, France, CEDEX) Anthony Turpin (Lille, France) Gael Roth (La Tronche, France) Thierry Lecomte (Chambray-lès-Tours, France) Jean-Baptiste Bachet (Paris, France) Elia Gigante (Reims, France) Romain Desgrippes (Saint Malo, France) Eric Assenat (Montpellier, France, CEDEX 5) Faiza Khemissa Akouz (Perpignan, France) Jean-charles Nault (Bobigny, France) Laurent Costes (Créteil, France) Marie Line Garcia Larnicol (Paris, France) Dewi Vernerey (Besancon, France) Cindy Neuzillet (Boulogne-Billancourt, France) Julien Edeline (Rennes, France, CEDEX)

 

 

Early changes in body composition independently predict survival in patients (Pts) receiving immunotherapy for biliary tract cancers (BTC): An ancillary study of the IMMUNO-BIL PRODIGE 57 GERCOR trial

Authors

Matthieu Delaye (Paris, France) Anna Dordonnat (Creteil, France) Frédéric Pigneur (Paris, France) Antoine Falcoz (Besancon, France) Eric Assenat (Montpellier, France, CEDEX 5) Laetitia Dahan (Marseille, France) Jean Frédéric Blanc (Bordeaux, France) David Tougeron (Poitiers, France, CEDEX) Jean-Philippe Metges (Brest, France) Astrid Lievre (Rennes, France) Meher Ben Abdelghani (Strasbourg, France) Clelia Coutzac (Lyon, France) Nadim Fares (Toulouse, France) Anthony Turpin (Lille, France) Marie Line Garcia Larnicol (Paris, France) Victoire Ruffino (Paris, France) Dewi Vernerey (Besancon, France) Cindy Neuzillet (Boulogne-Billancourt, France) Marc Hilmi (New York, United States of America)

Rapid ORAL Communication

 

Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study

Authors

Thierry André (Paris, France, CEDEX 12) Alessandra Raimondi (Milan, Italy) Dewi Vernerey (Besancon, France) Denis Smith (Pessac, France) Jean-Philippe Metges (Brest, France) David Tougeron (Poitiers, France, CEDEX) Guillaume Piessen (Lille, France) Antoine Adenis (Montpellier, France) Sabina Murgioni (Padua, Italy) Christelle De la Fouchardiere (Marseille, France, CEDEX) Christophe Tournigand (Creteil, France, CEDEX) Emilie Soularue (Paris, France) Clelia Coutzac (Lyon, France) Jérémie Lefevre (Paris, France) Florence Renaud (Paris, France) Marine Camus (Paris, France) Julie Henriques (Besancon, France) Marie Line Garcia Larnicol (Paris, France) Filippo Pietrantonio (Milan, Italy)

 

About Sophie PAGET-BAILLY


Sophie Paget-Bailly is a research engineer in epidemiology and clinical research. She passed with honours the East of France inter-region master’s degree in public health and occupational and environmental risks. During the master’s degree’s internship in the Interregional Epidemiology Unit of Bourgogne/Franche-Comté, she realized a quantitative health risk assessment in the context of chemical contamination of groundwater. She defended a PhD in Public Health and Epidemiology in Paris XI University, Doctoral School 420, working in the Centre for Research in Epidemiology and Population Health in Villejuif, France. Her PhD research focused on occupational exposures and head and neck cancer. 

2015-2026 © Copyright - UMQVC.org

Website by Pearlweb